Eton Pharmaceuticals (ETON) EPS (Basic) (2018 - 2025)

Eton Pharmaceuticals has disclosed EPS (Basic) across 8 years of filings, most recently posting $0.06 for Q4 2025.

• EPS (Basic) for Q4 2025 came in at $0.06, up 300.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.17 (down 6.25% YoY), and the FY2025 annual result was -$0.17, down 13.33% from the prior year.
• EPS (Basic) came in at $0.06 for Q4 2025 at Eton Pharmaceuticals, up from -$0.07 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $0.21 in Q1 2021 to a low of -$210.0 in Q1 2022.
• The 5-year median for EPS (Basic) is -$0.06 (2022), against an average of -$10.53.
• Across the five-year window, EPS (Basic) sank 100100.0% in 2022 and soared 400.0% in 2023, its largest moves.
• Eton Pharmaceuticals' EPS (Basic) stood at $0.04 in 2021, then increased by 0.0% to $0.04 in 2022, then sank by 325.0% to -$0.09 in 2023, then jumped by 66.67% to -$0.03 in 2024, then surged by 300.0% to $0.06 in 2025.
• The last three EPS (Basic) figures came in at $0.06 (Q4 2025), -$0.07 (Q3 2025), and -$0.1 (Q2 2025), per Business Quant data.